Follow the Vistin Pharma ASA share price and the full insider trade history of the company, a listed equity based in Norway. Shares are quoted on NO NO, under the oversight of Oslo Børs. Operating in the Healthcare & Pharma sector, Vistin Pharma ASA has logged 18 reports. Market capitalisation: €909.1m. The latest transaction was reported on 20 February 2026 (Other). Among the most active insiders: Unknown insider (VISTN). Every trade is accessible without an account.
18
Insider Decl.
0
Thresholds
€2
1 ops.
Buy Volume
€12m
7 ops.
Sell Volume
19Σ signal
Buys €2€12m Sells
Fundamental score
Ranked 994 of 26,063 companies
80.6
score / 100
Value
76
Quality
85
FCF yld6.7%
Earn yld8.2%
EV/EBITDA7.6x
ROE22%
Gross mgn51%
Net mgn17%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
10,000 shares@ NOK 17.3099.5% of flowShareXOSLOSLO:522056
18 of 18 declarations
About Vistin Pharma ASA
Vistin Pharma ASA is a Norwegian company focused on the development and production of pharmaceuticals for the treatment of metabolic diseases. It is listed on the Oslo Stock Exchange under the symbol XOSL.